World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
97
Citations
29954
World Ranking
1770
National Ranking
978

Medicine

D-Index
97
Citations
29955
World Ranking
9399
National Ranking
4848

Charalabos Pothoulakis publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Charalabos Pothoulakis sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 479 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Charalabos Pothoulakis D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Charalabos Pothoulakis sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 97 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Charalabos Pothoulakis is affiliated with the University of California, Los Angeles in the United States. Their research spans multiple areas within medicine and biochemistry, genetics, and molecular biology.

The primary fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

The scientist's work extends to several subfields of study:

  • Molecular Biology
  • Immunology
  • Neurology
  • Infectious Diseases
  • Cancer Research

The main research topics covered by Charalabos Pothoulakis are:

  • Clostridium difficile and Clostridium perfringens research
  • Gastrointestinal motility and disorders
  • Extracellular vesicles in disease
  • MicroRNA in disease regulation
  • Barrier Structure and Function Studies
  • Circular RNAs in diseases
  • Phagocytosis and Immune Regulation

Frequent co-authors of Charalabos Pothoulakis include:

  • Carl R. Rankin
  • Ivy Ka Man Law
  • Elizabeth J. Videlock
  • Artin Soroosh
  • Jill M. Hoffman

They have published extensively in several scientific venues, with a notable presence in:

  • Gastroenterology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Physiology-Gastrointestinal and Liver Physiology
  • Cell Death and Disease
  • Proceedings of the National Academy of Sciences

Some recent papers authored include:

  • The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling (2021, Gastroenterology)
  • Mice expressing fluorescent PAR 2 reveal that endocytosis mediates colonic inflammation and pain (2022, Proceedings of the National Academy of Sciences)
  • Role and mechanisms of exosomal miRNAs in IBD pathophysiology (2020, American Journal of Physiology-Gastrointestinal and Liver Physiology)
  • Blockage of protease-activated receptor 2 exacerbates inflammation in high-fat environment partly through autophagy inhibition (2020, American Journal of Physiology-Gastrointestinal and Liver Physiology)
  • Posttranslational modifications as therapeutic targets for intestinal disorders (2021, Pharmacological Research)

Best Publications

  • Principles and clinical implications of the brain-gut-enteric microbiota axis.

    Sang H. Rhee;Charalabos Pothoulakis;Emeran A. Mayer

  • Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms

    Elena Piskounova;Christos Polytarchou;James E. Thornton;James E. Thornton;Robert J. LaPierre;Robert J. LaPierre

  • Mechanisms and Metabolic Implications of Regional Differences among Fat Depots

    Tamara Tchkonia;Thomas Thomou;Yi Zhu;Iordanes Karagiannides

  • Tachykinins and Their Receptors: Contributions to Physiological Control and the Mechanisms of Disease

    Martin S Steinhoff;Bengt von Mentzer;Pierangelo Geppetti;Charalabos Pothoulakis

  • Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.

    I Castagliuolo;M F Riegler;L Valenick;J T LaMont

  • Enteric Glia Regulate Intestinal Barrier Function and Inflammation Via Release of S-Nitrosoglutathione

    Tor C. Savidge;Tor C. Savidge;Paul Newman;Charalabos Pothoulakis;Anne Ruhl

  • Trefoil Peptide Protection of Intestinal Epithelial Barrier Function: Cooperative Interaction With Mucin Glycoprotein

    Heather Kindon;Charalabos Pothoulakis;Lars Thim;Kathryn Lynch-Devaney

  • Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.

    G Hecht;C Pothoulakis;J T LaMont;J L Madara

  • Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.

    M Riegler;R Sedivy;C Pothoulakis;G Hamilton

  • Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns.

    Tamara Tchkonia;Marc Lenburg;Thomas Thomou;Nino Giorgadze

  • Neuropeptide substance P and the immune response

    Alireza Mashaghi;Anna Marmalidou;Mohsen Tehrani;Peter M. Grace

  • Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.

    Charalabos Pothoulakis;Ciaran P. Kelly;Manher A. Joshi;Ning Gao

  • Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders

    Theodoros Kelesidis;Charalabos Pothoulakis

  • Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury

    Madhav Bhatia;Ashok K. Saluja;Bernd Hofbauer;Jean Louis Frossard

  • Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia

    Sylvie Bradesi;Ines Schwetz;Helena S. Ennes;Christophe M. R. Lamy

  • Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin

    Donald Y.M. Leung;Ciaran P. Kelly;Mark Boguniewicz;Charalabos Pothoulakis

  • Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells

    I. Castagliuolo;J. T. Lamont;B. Qiu;S. M. Fleming

  • Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.

    I Castagliuolo;J T LaMont;S T Nikulasson;C Pothoulakis

  • Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.

    Amir Qamar;Samer Aboudola;Michel Warny;Pierre Michetti

  • Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea

    Stavros Sougioultzis;Lorraine Kyne;Denise Drudy;Sarah Keates

Frequent Co-Authors

Dimitrios Iliopoulos
Dimitrios Iliopoulos University of California, Los Angeles
Ignazio Castagliuolo
Ignazio Castagliuolo University of Padua
Ciaran P. Kelly
Ciaran P. Kelly Beth Israel Deaconess Medical Center
Emeran A. Mayer
Emeran A. Mayer University of California, Los Angeles
Mary Pat Moyer
Mary Pat Moyer Incell Corporation (United States)
Stephan R. Targan
Stephan R. Targan Cedars-Sinai Medical Center
Lin Chang
Lin Chang University of California, Los Angeles
Michael J. O'Brien
Michael J. O'Brien Tulane University
Tor C. Savidge
Tor C. Savidge Baylor College of Medicine
Jeremy J.W. Chen
Jeremy J.W. Chen National Chung Hsing University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students in Biology and Biochemistry, online and graduate-level healthcare programs can open the door to a variety of high-impact careers. The expanding number of cahme accredited mha programs allows you to study healthcare administration with flexible schedules, ideal for science graduates seeking leadership roles in the healthcare sector.

Those interested in advanced nursing can consider online dnp programs without clinicals, which focus on leadership, policy, and evidence-based practice—no on-site clinicals required. Similarly, doctoral programs for healthcare administration offer thorough training in management, policy-making, and healthcare systems, preparing scientists for executive positions.

For bioscience graduates aiming to transition into pharmacy, there are now online pharmd programs for non pharmacists, providing a pathway to pharmacist licensure through remote learning. These online programs cater to diverse professional goals, allowing flexibility and access to top-tier education while advancing your scientific career in healthcare settings.

Best Scientists Citing Charalabos Pothoulakis

Trending Scientists

Recently Published Articles